Importance of Device-Specific Follow-Up for Patients Post Standard EVAR for Abdominal Aortic Aneurysm
AORTA · 01.10.2023 · 11 (05) · 1-18
DOI: 10.1055/s-0044-1787921 ↗Kurz gefasst
Fachartikel in der Zeitschrift AORTA, erschienen am 01.10.2023. Verfasst von T. Cohnert und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Within the established method of endovascular aneurysm repair long-term results and device durability are problematic in some devices, with FDA warnings issued for AAA treatment using specific devices. Problem definition: For the Endologix AFX system component separation is a specific complication with the risk of acute AAA rupture. A patient died due to rupture caused by component separation during a hospital stay for preparation of re-intervention. Work summary: All patients who underwent standard EVAR using an Endologix AFX system between October 2015 and December 2023 were actively recalled and underwent physical examination, plain abdominal X-ray and CT Angiography.
Results
Out of 639 patients with elective AAA-repair 260 patients underwent EVAR. The 2 component Endologix AFX™ stent graft was used in 28 patients. No intra- or perioperative mortality occurred. All Endologix pts were actively recalled. 11 patients (42%) had died after median follow-up of 23 months (range 1-49 months), of these one patient post 49 months due to component dislocation and confirmed AAA rupture. 3 patients are lost to follow-up. Median survival in the 14 patients alive is 66 months. In 4 patients the AAA is shrinking, in 4 patients stable but not shrinking, in 4 patients growing under surveillance. Component separation was found in 2 patients, one treated successfully by relining 68 months post primary implantation. 16 of the 28 patients did not adhere to the given follow-up schedule and did not present for the appointments scheduled.
Conclusion
Life-long follow-up post EVAR is important. A strategy to ensure that patients follow the radiographic controls and device-specific follow-up plan is required. Device specific recommendations should be considered in AAA treatment guidelines. Publication History Article published online: 11 June 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
Zitieren
APA
Cohnert, T., Siegl, G., Koter, S., & Portugaller, H. (2023). Importance of Device-Specific Follow-Up for Patients Post Standard EVAR for Abdominal Aortic Aneurysm. AORTA, 11(05), 1-18. https://doi.org/10.1055/s-0044-1787921
Vancouver
Cohnert T, Siegl G, Koter S, Portugaller H. Importance of Device-Specific Follow-Up for Patients Post Standard EVAR for Abdominal Aortic Aneurysm. AORTA. 2023;11(05):1-18. doi:10.1055/s-0044-1787921
BibTeX
@article{Cohnert2023,
author = {Cohnert, T. and Siegl, G. and Koter, S. and Portugaller, H.},
title = {Importance of Device-Specific Follow-Up for Patients Post Standard EVAR for Abdominal Aortic Aneurysm},
journal = {AORTA},
year = {2023},
volume = {11},
number = {05},
pages = {1--18},
doi = {10.1055/s-0044-1787921}
}
EUVIMED